Skip to main content
. Author manuscript; available in PMC: 2019 Jan 1.
Published in final edited form as: Leuk Lymphoma. 2016 Jan 27;59(1):138–145. doi: 10.3109/10428194.2015.1136741

Table II.

Change in body composition during therapy

Measure of Body Compositiona At Diagnosis (mean±SE) End of Induction (mean±SE) End of Delayed Intensification (mean±SE) pb
Body Mass Index Percentile (BMI%) 70.5±5.5 61.6±5.2 62.8.±5.2 <0.001

Fat Mass (%) 28.6±1.3 33.9±1.3 37.1±1.3 <0.001
(kg) 19.4±1.7 20.9±1.7 24.1±1.7 <0.001

Lean Mass (%) 68.1±1.3 62.7±1.2 59.8±1.3 <0.001
(kg) 41.6±1.6 35.6±1.6 36.4±1.6 <0.001

Bone Mass (%) 3.28±0.094 3.43±0.091 3.10±0.092 <0.001
(kg) 1.99±0.080 1.94±0.080 1.86±0.080 <0.001
a

Body mass index percentile calculated from weight and height at time of visit according to CDC age- and sex- norms. Other parameters directly assessed via dual-energy X-ray absorptiometry.

b

p-value for percentages calculated from mixed-effect analysis of variance across time-points (see methods for additional detail).